2024-11-25 16:18:33
Innovent Announces First Overweight or Obese Subject Dosed in A Phase 2 Clinical Trial of IBI362 (a GLP-1 and Glucagon Receptor Dual Agonist) in China
Corporate/ 2023-07-23
Innovent Announces First Overweight or O...

SAN FRANCISCO and SUZHOU,China,June 15,2021--Innovent Biologics,Inc. ("Innovent") (HKEX: 01801),a world-class biopharmaceutical co...

WuXi XDC and LegoChem Biosciences Signed Memorandum of Understanding for the Development and Manufacturing of Antibody-drug Conjugates
Corporate/ 2023-07-23
WuXi XDC and LegoChem Biosciences Signed...

WUXI,China and DAEJEON,South Korea,June 10,2021-- WuXi XDC ("XDC"),a global CDMO company dedicated to end-to-end bioconjugates ser...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release